1. Home
  2. VIAV vs SUPN Comparison

VIAV vs SUPN Comparison

Compare VIAV & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIAV
  • SUPN
  • Stock Information
  • Founded
  • VIAV 1923
  • SUPN 2005
  • Country
  • VIAV United States
  • SUPN United States
  • Employees
  • VIAV N/A
  • SUPN N/A
  • Industry
  • VIAV Semiconductors
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • VIAV Technology
  • SUPN Health Care
  • Exchange
  • VIAV Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • VIAV 2.0B
  • SUPN 1.8B
  • IPO Year
  • VIAV 1993
  • SUPN 2012
  • Fundamental
  • Price
  • VIAV $9.11
  • SUPN $31.70
  • Analyst Decision
  • VIAV Buy
  • SUPN Hold
  • Analyst Count
  • VIAV 8
  • SUPN 2
  • Target Price
  • VIAV $12.69
  • SUPN $36.00
  • AVG Volume (30 Days)
  • VIAV 2.9M
  • SUPN 467.8K
  • Earning Date
  • VIAV 05-01-2025
  • SUPN 05-06-2025
  • Dividend Yield
  • VIAV N/A
  • SUPN N/A
  • EPS Growth
  • VIAV N/A
  • SUPN N/A
  • EPS
  • VIAV 0.02
  • SUPN 1.11
  • Revenue
  • VIAV $1,045,800,000.00
  • SUPN $667,997,000.00
  • Revenue This Year
  • VIAV $10.06
  • SUPN N/A
  • Revenue Next Year
  • VIAV $7.08
  • SUPN $8.74
  • P/E Ratio
  • VIAV $398.76
  • SUPN $28.64
  • Revenue Growth
  • VIAV 3.34
  • SUPN 11.82
  • 52 Week Low
  • VIAV $6.60
  • SUPN $25.53
  • 52 Week High
  • VIAV $12.91
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • VIAV 36.85
  • SUPN 45.77
  • Support Level
  • VIAV $8.92
  • SUPN $31.56
  • Resistance Level
  • VIAV $9.36
  • SUPN $32.85
  • Average True Range (ATR)
  • VIAV 0.21
  • SUPN 0.78
  • MACD
  • VIAV 0.03
  • SUPN -0.08
  • Stochastic Oscillator
  • VIAV 26.97
  • SUPN 13.56

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: